Cobimetinib and vemurafenib are now listed in the interaction checker as cancer drugs and interactions can be found with all the comedications.
- Cobimetinib (Cotellic®) is a MEK inhibitor and is indicated for the treatment of melanoma.
- Vemurafenib (Zelboraf®) is BRAF inhibitor and is indicated for the treatment of melanoma.
